Profile data is unavailable for this security.
About the company
Bangkok Lab and Cosmetic Public Company Limited is a Thailand-based producer and researcher of health products. The principal activities of the Company and subsidiaries are engaged in the manufacturing and distribution of pharmaceuticals and medicinal chemical products for humans and animals. It operates through the pharmaceuticals and medicinal chemical products segment. Its pharmaceutical business offers generic drugs, herbal medicine, and animal medicine. Its other health related products business offers cosmetics, food supplements, and other. The Company manufactures and supplies a wide range of food supplements for joints, muscles, bones, and eyesight in various forms, such as tablets and powder. Its cosmetics products include facials and skincare in various forms, such as creams, waxes, and gels. Its other products include medical devices such as silicone gel for surgical incisions and lubricating gel.
- Revenue in THB (TTM)1.68bn
- Net income in THB188.48m
- Incorporated2022
- Employees1.11k
- LocationBangkok Lab and Cosmetic PCL48/1 Moo 5 Nongshaesao Rd.Namphu, Mueang RatchaburiRATCHABURI 70000ThailandTHA
- Phone+66 32719900
- Fax+66 32719917
- Websitehttp://bangkoklab.co.th/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assertio Holdings Inc | 4.27bn | -898.38m | 2.47bn | 58.00 | -- | 0.7505 | 35.98 | 0.5781 | -4.71 | -4.71 | 20.93 | 16.49 | 0.4611 | 1.35 | 1.47 | 2,368,138.00 | -9.71 | -15.74 | -17.07 | -24.19 | 68.16 | 82.29 | -21.06 | -42.01 | 1.43 | -- | 0.2702 | -- | -17.83 | -11.45 | 93.50 | -- | -- | -- |
| Stella Pharma Corp | 197.04m | -56.81m | 2.47bn | 43.00 | -- | 4.51 | -- | 12.54 | -8.21 | -8.21 | 28.47 | 79.22 | 0.1966 | 0.0944 | 2.91 | 22,529,260.00 | -5.67 | -16.41 | -5.96 | -18.19 | 87.88 | 87.03 | -28.83 | -176.16 | 13.81 | -45.69 | 0.226 | -- | 256.62 | -- | 81.56 | -- | -21.34 | -- |
| Fabtech Technologies Ltd | -34.30bn | -34.30bn | 2.48bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 44.46 | -- | 70.67 | -- | -- | -- |
| Synthaverse SA | 470.53m | -53.03m | 2.48bn | 231.00 | -- | 2.03 | 43.97 | 5.28 | -0.0827 | -0.0827 | 0.7543 | 1.84 | 0.1807 | 1.41 | 2.16 | 232,688.30 | -2.04 | 3.30 | -2.36 | 3.91 | 61.45 | 57.46 | -11.27 | 10.33 | 0.742 | -0.5519 | 0.3923 | -- | 22.44 | 12.91 | 58.68 | 24.91 | 120.32 | -- |
| Polypid Ltd | 0.00 | -1.06bn | 2.50bn | 57.00 | -- | 4.80 | -- | -- | -2.98 | -2.98 | 0.00 | 0.9237 | 0.00 | -- | -- | 0.00 | -147.37 | -90.05 | -241.51 | -109.86 | -- | -- | -- | -- | -- | -22.38 | 0.1359 | -- | -- | -- | -21.61 | -- | -38.71 | -- |
| Bangkok Lab and Cosmetic PCL | 1.68bn | 188.48m | 2.51bn | 1.11k | 13.31 | 1.49 | 9.97 | 1.49 | 0.3141 | 0.3141 | 2.80 | 2.81 | 0.732 | 2.74 | 4.66 | 1,517,711.00 | 8.36 | 7.24 | 10.41 | 12.57 | 30.39 | 28.80 | 11.42 | 8.08 | 1.44 | 31.98 | 0.1135 | -- | 10.73 | 5.31 | 17.85 | 142.44 | 16.91 | -- |
| Zhongzhi Pharmaceutical Holdings Ltd | 9.03bn | 92.51m | 2.54bn | 2.49k | 26.82 | 0.5197 | 4.44 | 0.2812 | 0.0276 | 0.0276 | 2.69 | 1.42 | 1.05 | 2.66 | 6.45 | 882,003.30 | 1.09 | 6.77 | 1.68 | 10.47 | 57.19 | 59.64 | 1.03 | 5.91 | 1.06 | 51.80 | 0.1134 | 38.97 | 8.05 | 10.54 | -41.51 | -3.65 | 13.62 | 10.79 |
| Infant Bacterial Therapeutics AB | 0.00 | -277.54m | 2.56bn | 10.00 | -- | 6.11 | -- | -- | -5.92 | -5.92 | 0.00 | 9.23 | 0.00 | -- | -- | 0.00 | -38.19 | -22.82 | -48.56 | -24.41 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -11.24 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| MFC Asset Management Public Co., Ltd. (Investment Management)as of 30 Sep 2025 | 1.12m | 0.19% |
